Background: The availability of simple and accurate assays of plasma active renin (DRC) and aldosterone con centration (PAC) can improve the detection of secondary forms of arterial hypertension. Thus, we investigated the performance of an automated chemiluminescent assay for DRC and PAC in referred hypertensive patients. Methods: We prospectively recruited 260 consecu tive hypertensive patients referred to an ESH Center for Hypertension. After exclusion of six protocol violations, 254 patients were analyzed: 67.3% had primary hyperten sion, 17.3% an aldosterone producing adenoma (APA), 11.4% idiopathic hyperaldosteronism (IHA), 2.4% reno vascular hypertension (RVH), 0.8% familial hyperaldo steronism type 1 (FH1), 0.4% apparent mineralocorticoid excess (AME), 0.4% a reninproducing tumor, and 3.9% were adrenalectomized APA patients. BlandAltman plots and Deming regression were used to analyze results. The diagnostic accuracy (area under the curve, AUC of the ROC) of the DRCbased aldosteronerenin ratio (ARR CL ) was compared with that of the PRAbased ARR (ARR RIA ) using as reference the conclusive diagnosis of APA.
Introduction
Potentially curable secondary forms of arterial hyperten sion (HT) are markedly under diagnosed even though the ESH/ESC guidelines recommend that they be looked for in hypertensive patients fulfilling certain features [1] . This strategy recently led to detect these forms in about half of the patients with resistant HT referred to tertiary centers [2] , which is 50fold more than the current detection rate in common general clinical practice.
The under detection of secondary forms of HT not only results into lifelong costly medical treatment, but more importantly, into an excess damage of the target organs of HT, which translates into an excess rate of otherwise preventable cardiovascular events [3, 4] . Hence, this is a clinical disaster that needs urgent measures.
An accurate assessment of the renin angiotensin aldosterone system (RAAS) is key to a successful identification of secondary forms of HT [5] . Hence, the development of accurate assays for measuring renin and aldosterone that are simple, fast, and easy to implement in real life practice can represent a major leap forward to accelerate and facilitate diagnosis and decrease the costs of undiagnosed HT. To this aim, nonradioactive methods for the simultaneous measurement of active renin and aldosterone are much desirable, as they are less laborand timeconsuming and thus ultimately cheaper. Moreover, for renin measurement they have the theoretical advantage over plasma renin activity (PRA) of the independence of renin on its substrate (angiotensinogen).
Several studies have evaluated chemiluminescent assays for measuring the plasma concentration of active renin (DRC) and aldosterone in hypertensive patients [6] [7] [8] [9] [10] [11] . These studies, albeit showing that compared to the radioimmunometric methods the DRC assay allowed saving labor time and costs, overall had limitations in that most of them were designed to compare PRA to DRC [6, [8] [9] [10] [11] [12] , rather than to test the diagnostic accuracy of the aldosteronerenin ratio (ARR) based on DRC (ARR CL ) and the PRAbased ARR (ARR RIA ), for identifying the sub types of primary aldosteronism that can be diagnosed conclusively. Therefore, no such studies followed the STARD recommendations for estimating diagnostic accu racy [13] , which dictate that a mandatory step before any novel test can be introduced in clinical practice entails validation using a "gold standard" as reference. Of note, a conclusive diagnosis of APA (based on the "four corners criteria" [5] ), and of FH1 (based on genetic testing) was never used as reference in these studies. Notwithstand ing this, the chemiluminescent assays of renin have rapidly replaced the PRA at many centers, which is much worrying as their superiority, or even equivalence, in terms of diagnostic accuracy over the PRA assay was never proven.
This study was therefore, set up to prospectively evaluate the diagnostic accuracy of a novel chemilumi nescent automated assay for DRC and PAC in a cohort of consecutive referred patients with HT in whom a conclu sive diagnosis of APA was achieved.
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Materials and methods

Study design
The study protocol followed the requirements of the Declaration of Helsinki and the Statement for reporting Studies of Diagnostic Accuracy (STARD) recommendations [5, 13] . The flowchart of the study is shown in Figure 1 : in brief, paired plasma samples from each patients were collected and submitted to preanalytical handling as required for the DRC and the PRA assays. Two technicians, each kept totally blind to clinical data, the conclusive diagnosis of the type of HT, and to the results of the other renin and PAC measurements, independently performed the assays. Based on previous experience [14] we determined beforehand that at least 230 patients were needed to achieve acceptable results; given an anticipated attrition rate a 10% we enrolled 260 consecu tive consenting patients referred to the Clinica dell'Ipertensione Arteriosa, Centro Regionale Specializzato, Regione Veneto, Center of Excellence of the ESH, for the evaluation of HT. Exclusion criteria entailed heart failure, liver cirrhosis, type 1 diabetes mellitus, and any other major illness that could affect life expectancy and/or the renin angiotensinaldosterone system. An Adjudication Committee made by experienced clinicians (GPR, TMS and GM) made the final diagnosis of the cause of HT.
Subjects and methods
For a detailed description of the pharmacological preparation of the patients and the conditions for testing, please refer to the Supple mental Material.
Biochemical measurements
All biochemical measurements were centralized and performed in the ISO 9001certified central laboratory of the Azienda Università OspedalePadova as detailed in the Supplemental Material.
DRC and PAC were measured shortly after blood sampling in the ad hoc collected samples using an automated system (DiaSorin, LIAISON ® XL instrument), the LIAISON ® Direct Renin kit (DiaSorin, Saluggia, Italy) and the LIAISON ® XL Aldosterone kit. Normal ranges and antibody crossreactivity for the hormonal measurements have already been reported [5] .
ARR RIA and the ARR CL calculation and diagnostic criteria
The ARR was first calculated using PAC (in ng/dL) as numerator, and either DRC (in mIU/L, ARR CL ) or PRA (in ng/mL/h, ARR RIA ) values as denominator. The ARR value was also recalculated after setting the lowest possible value of the denominator to 0.6 mIU/L (corresponding to the 25th percentile) and to 0.2 ng/mL/h for the DRC and PRA, respec tively, as described [14] , to avoid over inflation due to low renin levels.
Primary aldosteronism (PA) was diagnosed in the presence of bio chemical evidence of PA, as shown by an elevated ARR RIA : for the diag nosis of APA lateralized aldosterone excess at adrenal vein sampling (AVS); identification of APA at surgery and/or pathology; demonstration of correction of the hyperaldosteronism and cure, or marked improve ment of the hypertension postadrenalectomy, e.g. the "four corner cri teria", were also required [5] . Patients with a high ARR RIA , who showed no lateralized aldosterone excess, were presumed to have idiopathic hyperaldosteronism (IHA). Renovascular hypertension was diagnosed based on demonstration of a hemodynamically significant renal artery stenosis at angioCT using the METRAS Study criteria [15] , and a fall greater than 20 mmHg systolic and diastolic blood pressure on the same or lowered antihypertensive drugs (dose and/or number) after renal revascularization [15] ; familial hyperaldosteronism type 1 (FH 1) was diagnosed by long PCR [16] ; reninproducing tumor (RPT) was diagnosed based on biochemistry, imaging and renal venin sampling.
Further tests
The patients with an ARR exceeding the cutoff values at baseline and postcaptopril (27 and 13 ng/dL/ng/mL/h, respectively) [5] were submitted to AVS to identify a lateralized aldosterone excess produc tion, and to an imaging test for identification of adrenocortical nodule [5, 17, 18] . Only bilaterally selective AVS were used to demonstrate lat eralization of hyperaldosteronism [18] . As the bilateral simultaneous blood sampling technique was used, we did not perform AVS with cosyntropin because we previously showed that despite improving the assessment of selectivity of catheterization this stimulation does not enhance the diagnostic accuracy [19] .
Statistical analysis
DRC, PRA, PAC, and ARR values were skewed and therefore, were analyzed after a normal distribution was achieved by log transforma tion. Oneway ANOVA with Bonferroni's posthoc test was used to com pare quantitative variables across groups. Distribution of categorical variables was investigated by χ 2 analysis. BlandAltman plots and Dem ing regression analysis were used to assess the withinpatient relation ship between DRC and PRA, and between PAC RIA and PAC CL values [20] . BlandAltman plots were used to detect systematic error, proportional error, or a magnitudedependent bias. For the Deming regression, the concordance correlation coefficient, which evaluates the degree to which pairs of observations fall on the 45° line through the origin, was calcu lated. This coefficient is a measure of accuracy and was estimated by the following formula: ρc = ρ Cb, with ρ indicating the Pearson correlation coefficient and Cb indicating a bias correction factor that measures how far the bestfit line deviates from the 45° line through the origin. Given the different ranges of values furnished by these assays the Z score were calculated from the raw values and used for the latter analyses.
The receiver operator characteristics (ROC) curves were employed to assess the accuracy of the ARR CL and the ARR RIA for identifying APA [21] . The area under the ROC, used as an estimate of diagnostic accuracy, was compared between the ARR CL and the ARR RIA with the method of Hanley [22] . The Youden index (J), a main summary statistic of the ROC curve defined as J = max (c) [sensitivity (c)+specificity (c)−1], was employed to determine the optimal cutoff (c*). This was defined as the value that optimizes the ARR's dis criminating ability in that it corresponds to the highest average of sensitivity and specificity [23] . The significance was set at p < 0.05. SPSS™ for Mac (vers. 22.0) was used for all but the ROC curve analy ses, which were performed with the MedCalc TM software (vers. 15.6 MedCalc Software, Mariakerke, Belgium).
Results
Baseline characteristics
Between April 2014 and April 2015 260 consecutive newly referred patients with HT were recruited. Of them six were excluded due to protocol violations, missing data or , PAC-to-DRC ratio calculated using PAC measured with chemiluminescent assay as numerator and DRC as denominator, at baseline; ARR c CL , PAC-to-DRC ratio calculated using PAC measured with chemiluminescent assay as numerator and DRC as denominator, after captopril. duplicated (n =1). Of the remaining 254 patients, 67.3% had primary hypertension (PH) and 32.7% secondary HT. In the latter group, 17.3% (of the total) had an APA, 11.4% IHA, 2.4% RVH due to atherosclerotic renal artery stenosis, 0.8% (two patients) FH1, 0.4% (one patient) apparent mineralo corticoid excess due to licorice abuse and 0.4% (one patient) reninproducing tumor; 3.9% (ten patients) were adrenal ectomized APA patients studied at followup after surgery. The demographic and clinical data of the entire cohort of consecutive hypertensive patients (Table 1) showed that the patients were middle aged, overweight, with normal sodium intake and renal function. Table 2 shows the clini cal and the raw biochemical data of the patients in the three main groups of diagnosis; the adrenalectomized PA patients were not included as PA in the overall analysis. The PA patients showed the lowest values of serum K + , PRA and DRC; both the PA and the RVH showed high PAC; however, only the former exhibited overtly elevated values of the ARR, regardless of the assays used for its determina tion. When the PA, which comprised the largest group with secondary HT, was examined, the APA patients showed slightly lower serum K + , and higher PAC and ARR values, albeit only for the ARR CL . The blood pressure values were significantly lower in the adrenalectomized APA than in the APA studied before adrenalectomy; moreover, their PRA and DRC values increased, and the PAC values fell, as com pared to the preadrenalectomy group (Table S1 ). The base line and postcaptopril values of the ARR RIA and ARR CL in the patients divided by final diagnosis (Figure 2 ) evidenced a remarkable similarity between values determined with either method across all groups. The corresponding values of PRA, DRC, and PAC also showed prominent similarity ( Figures S1 and S2) , as assessed by the concordance cor relation coefficient, which was 0.92 and 0.93 for renin and PAC, respectively ( Figure S3 ).
Relationship between the DRC and the PRA and PAC RIA and PAC CL The DRC and PRA values showed a significant withinpatient correlation in the whole cohort, both at baseline (r = 0.91 (0.89-0.93), p < 0.0001 and postcaptopril (r = 0.88 (0.85-0.91), p < 0.0001), thus indicating a high between method concordance in the all range of plasma renin levels ( Figure S3 ). The PAC RIA and PAC CL values also showed a sig nificant within-patient correlation in the whole cohort, both at baseline (r = 0.93 (0.91-0.94), p < 0.0001) and post captopril (r = 0.88 (0.84-0.90), p < 0.0001). Therefore, there was a high betweenmethod concordance in a wide range of PAC levels spanning from those found in patients with low PAC (AME and FH1 under dexamethasone treatment) and high PAC values (PA and RVH patients). Figure 3 shows the BlandAltman plot of the ARR RIA and the ARR CL . The Z scores were used for this plot to avoid cre ating an artificial proportional error (due to the different units of measure of the assays). Although eyeball exami nation suggested a 'funnel effect', e.g. a magnitude related (proportional) difference between the methods, no evidence for systematic biases was detected: only 10 of the 254 values fell out of the 95% confidence interval. The ROC curves AUC for ARR CL and ARR RIA for the unambiguously diagnosed APA, used as reference, dif fered significantly from that under the identity line, for both ARRs indicating that they provided a diagnostic gain in over tossing a coin (Figure 4) . However, the AUC for ARR CL was higher than that for ARR RIA (p = 0.02). Results were similar when the analysis was repeated after con straining the lowest value of DRC to 6 mIU/L, and the PRA to 0.2 ng/mL/h, the values used in clinical practice when calculating the ARR to avoid overinflating its values due to exceedingly low renin values [5, 24] .
Diagnostic accuracy of the ARR RIA and the ARR CL
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Optimal cutoff of the ARR CL for identification of APA
The Youden index, used to identify the optimal cutoff for the raw and corrected ARR CL , was 2.06 for the raw ARR CL expressed as PAC in ng/dL and DRC as mUI/L, which corresponded to a sensitivity of 92% and a speci ficity of 91.6% (Table 3 ). For the ARR RIA the optimal cutoff value (in ng/dL/ng/mL/h) was 38.7, corresponding to a sensitivity of 80% and a specificity of 92%. Results were similar when the analysis was repeated after constrain ing the lowest DRC value to 6 mIU/L, and the PRA to 0.2 ng/mL/h.
Discussion
The direct immunochemical measurement of active renin is rapidly replacing PRA for several potential advantages including independence on renin substrate availability, more consistent results, handling of plasma at room tem perature, and the possibility of performing the assay with automation, thus saving time, costs and human resources. Accordingly, the replacement of the PRA with the chemi luminescent renin assay has rapidly occurred at many centers in spite of lack of any proof for superiority of the former over the latter in terms of diagnostic accuracy. The available studies mostly investigated the correlation of DRC with DRA [6] [7] [8] [9] [10] [11] ; only one retrospective study vali dated a chemiluminescent assay in PA patients, but did not compare the ARR CL , with the ARR RIA [12] .
We planned this study in 2013 to prospectively compare headtohead the ARR obtained from an auto mated simultaneous chemiluminescent measurement of PAC and DRC (ARR CL ) with the ARR based on established and clinically validated PRA and PAC radioimmunoassay (ARR RIA ) in a sizable cohort of patients. According to the protocol, we selected no specific forms of HT as we wished to test the performance of these assays in a real life situ ation entailing a cohort of consecutively referred hyper tensive patients. Hence, we recruited mostly patients with essential HT, but also, consistently with the referral nature of our center, a notable proportion with secondary forms of HT, among which primary aldosteronism largely prevailed, but other forms, including renovascular HT, FH1, reninproducing tumor, and apparent mineralocor ticoid excess were also represented. Moreover, as a result of our policy of systematically assessing the patients postadrenalectomy to prove correction of the PA, there were also APA patients who were studied at followup postadrenalectomy. Altogether these features testified the 'real life' setting of this study and allowed to compare the two assays over a wide range of renin and PAC values.
Of note, the secondary forms of HT were diagnosed unambiguously by stateofthe art criteria: for APA and FH1, the subtypes of PA that can be unequivocally diag nosed, by the "four corners criteria" and long PCR, respec tively [5, 17] . Since, as expected FH1 was found only in two The arrow and bold indicate the cutoff value that meets the optimal sensitivity and specificity. +PV, positive predictive value; -PV, negative predictive value; +LR, positive likelihood ratio; -LR, negative likelihood ratio [25] .
cases, we used APA as reference index to determine the accuracy of either ARR following the STARD recommen dations [13] . The diagnostic accuracy of the ARR CL and the ARR RIA for identifying APA could then be compared using the ROC curve analysis. When the entire cohort was examined, both the PRA and DRC, and the PAC values, and consequently the ARR RIA and ARR CL (Figure 2) showed remarkably similar results and, more importantly, the expected differences across diagnosis groups (Table 2 and Figures S1 and S2) .
The renin values were lower in the PA group than in the PH and the RVH group with both assays; moreover, both PAC RIA and PAC CL values were higher in the PA and RVH patients than in the PH patients, as expected. Of note, the highest DRC value was observed in the patient with the reninproducing tumor, in which the PRA values were not so prominently elevated. This finding, along with the fact that another such case was identified at our center in the past few months after the introduction of the DRC assay, suggests that this assay, by circumventing the underesti mation of renin with the PRA assay (due to dependency on limiting) substrate availability), can improve the detec tion of rate of this rare cause of HT.
We found that the DRC and PRA values were tightly withinpatient correlated in the whole cohort, both for the baseline and for the postcaptopril stimulation ( Figure S3 ). This finding is at variance with what we found in a smaller retrospectively investigated cohort of the PAPY study, where only the postcaptopril PRA and DRC values correlated strongly [14] . We speculated at that time that the stronger correlation postcaptopril could be because of the higher precision of both renin assays when renin values are raised. Instead the present find ings showed that the PRA and DRC correlated well also in the low renin range, e.g. in PA patients under unstimu lated conditions. Likely this different better outcome orig inated from several factors: the very rigorous control of the preanalytical phase that avoided inadvertent altera tion of renin measurement due to cryoactivation [6, 26] , use of an automated method in a centralized laboratory, along with a storage time duration much shorter than in the PAPY Study [14] .
The notable precision of the automated DRC assay to measure the low renin levels of PA patients agrees with the findings of a highly significant correlation between PRA and DRC in plasma samples with low renin concentration (mean value of 1.63 mIU/L, range 0.8-11.7) in PA patients, as well as with the manufacturer's claim that the LIAISON Direct Renin kit has a functional sensitivity of 2 (1.60-1.96 IFU DS) mIU/L. This finding is obviously relevant from the practical standpoint and supports the contention that the ARR CL could be at least as accurate as ARR RIA in identifying PA patients [18] .
To further investigate the accuracy of the two ARR we used the AUC under the ROC curves, which estimates the overall diagnostic accuracy because it provides an index of the average sensitivity for all values of specificity, and vice versa. For the ARR CL and the ARR RIA the AUC was higher than 0.50, indicating that both tests are useful for the screening of APA over "tossing a coin". More impor tantly, the accuracy of the ARR CL was higher than that of the ARR RIA : a formal comparison of the ARR CL and the AUC ARR RIA showed that the AUC for the former test (0.974 (95% CI 0.940-0.991) was higher than that of the latter (0.894 (95% CI 0.841-0.933, p = 0.02) (Figure 4 ). Identi cal conclusions were reached when the ROC analysis was repeated after constraining the lowest limit of DRC and PRA measured renin values at the aforementioned minimum values.
The optimal cutoff for the raw ARR CL (expressed as PAC in ng/dL and DRC as mIU/L, Table 2 ), was 2.06; it corresponded to a sensitivity of 92% and a specificity of 92% (Table 3) ; for the ARR RIA the optimal cutoff value was 38.7 (expressed as PAC in ng/dL and PRA as ng/mL/h) corresponding to a sensitivity of 80% and a specificity of 92%. This ARR CL cutoff is higher than the 1.2 reported for another chemiluminescent assay in a retrospective study, in which, however, the diagnosis of APA was not unam biguously confirmed by the four corner criteria (12) . With that cutoff, however, in spite of slightly higher sensitivity (98.9% vs. 92%) the specificity was much lower compared to that found in the present study (79% vs. 92%). More over, to enable readers to select the ARR CL cutoff values that best meet their desired combination of sensitivity and specificity we have provided a table with the sensitivity, specificity, positive (+PV) and negative predictive value (-PV), positive likelihood ratio (+LR), negative likelihood ratio (-LR), and also the optimal criterion value, which takes into account not only sensitivity and specificity, but also disease prevalence, and costs of various decisions (Table 3) .
It might be argued that extrapolation of these find ings to the general population of hypertensives is not warranted because we examined patients referred to a specialized hypertension center, who show a prevalence of secondary forms of hypertension much higher than that found in the hypertensive patients commonly seen in general practice. However, the prevalence of second ary forms of HT was lower than the 50% reported in a recent multicenter study of patients with resistant HT [2] ; moreover, our cohort had an overall prevalence of PA of 27%, higher than that (11.2%) found in the all PAPY Study [5] . Nonetheless, the rate of the different subtypes was similar, which would speak against a selection bias and overall support the generalizability of our findings to the population of referred hypertensive patients.
Strengths of this study include its prospective design, a careful standardization of the conditions for patient's preparation, blood sampling and biochemical assay (see Supplemental Material), and, moreover, se of an accepted methodology based on the conclusive diagnosis of secondary HT, namely of APA, as reference index for the diagnosis of PA [5, 17, 27] .
These results allow, in our view, the following conclu sions: in patients adequately prepared from the pharma cological standpoint, when samples are properly collected and handled under carefully standardized conditions, the diagnostic performance of the ARR based on DRC is equiv alent to that based on a clinically validated PRA assay in a wide range of clinical conditions. Moreover, for the detec tion of PA, a common cause of secondary HT that is most challenging for the renin assays because of its low or very low renin values, the ARR CL obtained from PAC and DRC measured with an automated chemiluminescent method performed better than the ARR RIA . Major advantages of the this method for estimating active renin over the PRA assay include a simpler preanalytical handling with blood collection and at room temperature and automa tion, which translated in more reproducible results and in less handson use of human resources. Finally, lack of use of radioactivity and radioactive waste make these assays environment friendly. Based on these considerations we have now introduced the chemiluminescencebased assays instead of the PRA and PAC radioimmunoassay at our institution. This has allowed a marked shortening of the time from blood sampling to results, with the benefits of speeding up reaching the diagnostic conclusions.
